- QMRO Home
- Barts Cancer Institute
- Centre for Haemato-Oncology
- Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma
Browse
Administrators only